Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study
American Journal of Hematology · 2024-06 · 99 (6) · 1201-1204
DOI: 10.1002/ajh.27300 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 02.04.2024. Verfasst von Bruno Fattizzo und 14 weiteren Autor:innen. Beteiligte Einrichtung: SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Glycolysis, Pyruvate Kinase, Erythrocytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Agios Pharmaceuticals.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
- Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
- Institute of Molecular Bioimaging and Physiology of the Italian National Research Council (IBFM-CNR), Segrate (MI), Italy.
- ISBE Elixir European Infrastructure for Systems Biology, Milan, Italy.
ORCID-Profile: Bruno Fattizzo, Loredana Pettine, Marta Bortolotti, Paola Bianchi, Anna Zaninoni, Wilma Barcellini
Förderung
- Agios Pharmaceuticals
Zitieren
APA
Fattizzo, B., Vercellati, C., Marcello, A., Patel, P., Wind-Rotolo, M., Pettine, L., Bonanomi, M., Gaglio, D., Bortolotti, M., Leoni, C., Fermo, E., Bianchi, P., Zaninoni, A., Passamonti, F., & Barcellini, W. (2024). Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study. American Journal of Hematology, 99(6), 1201-1204. https://doi.org/10.1002/ajh.27300
Vancouver
Fattizzo B, Vercellati C, Marcello A, Patel P, Wind-Rotolo M, Pettine L, et al. Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study. American Journal of Hematology. 2024;99(6):1201-1204. doi:10.1002/ajh.27300
BibTeX
@article{Fattizzo2024,
author = {Fattizzo, Bruno and Vercellati, Cristina and Marcello, Anna and Patel, Parija and Wind-Rotolo, Megan and Pettine, Loredana and Bonanomi, Marcella and Gaglio, Daniela and Bortolotti, Marta and Leoni, Claudia and Fermo, Elisa and Bianchi, Paola and Zaninoni, Anna and Passamonti, Francesco and Barcellini, Wilma},
title = {Glycolytic activity and in vitro effect of the pyruvate kinase activator AG ‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study},
journal = {American Journal of Hematology},
year = {2024},
volume = {99},
number = {6},
pages = {1201--1204},
doi = {10.1002/ajh.27300}
}
EUVIMED